BioLineRx to Report Third Quarter 2024 Results on November 25, 2024
Go back to BioLineRx to Report Third Quarter 2024 Results on November 25, 2024| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.22 +0.01 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.21 | 52 Week High | $1.63 | |||
| Open | $2.20 | 52 Week Low | $0.71 | |||
| Day High | $2.27 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $0.00 | |||
| Volume | 9,686 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.22 +0.01 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.21 | 52 Week High | $1.63 | |||
| Open | $2.20 | 52 Week Low | $0.71 | |||
| Day High | $2.27 | P/E | N/A | |||
| Day Low | $2.20 | EPS | $0.00 | |||
| Volume | 9,686 | |||||



